Search research articles
Contact Us
Filters
Showing results (1-10 of 79) with videos related to
Page
of 8
Sort By:
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
November 28, 2007
Strategies for intranasal delivery of therapeutics for the prevention and treatment of neuroAIDS
Leah R Hanson, William H Frey
BMC Neuroscience
|
December 19, 2008
Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease
Leah R Hanson, William H Frey
Neuroscience Letters
|
March 6, 2012
Intranasal delivery of siRNA to the olfactory bulbs of mice via the olfactory nerve pathway
Dan B Renner, William H Frey, Leah R Hanson
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
January 4, 2020
Intranasal Insulin: a Treatment Strategy for Addiction
Bhavani Kashyap, Leah R Hanson, William H Frey Ii
The Journal of Pharmacology and Experimental Therapeutics
|
October 24, 2008
Novel vasoconstrictor formulation to enhance intranasal targeting of neuropeptide therapeutics to the central nervous system
Shyeilla V Dhuria, Leah R Hanson, William H Frey
Molecular Pharmaceutics
|
April 28, 2010
Trigeminal pathways deliver a low molecular weight drug from the nose to the brain and orofacial structures
Neil J Johnson, Leah R Hanson, William H Frey
Journal of Pharmaceutical Sciences
|
November 26, 2008
Intranasal drug targeting of hypocretin-1 (orexin-A) to the central nervous system
Shyeilla V Dhuria, Leah R Hanson, William H Frey
Journal of Pharmaceutical Sciences
|
October 31, 2009
Intranasal delivery to the central nervous system: mechanisms and experimental considerations
Shyeilla V Dhuria, Leah R Hanson, William H Frey
Pharmaceuticals (Basel, Switzerland)
|
February 26, 2025
Brain Glucose Hypometabolism and Brain Iron Accumulation as Therapeutic Targets for Alzheimer's Disease and Other CNS Disorders
Indira Y Rao, Leah R Hanson, William H Frey Ii
Pharmaceuticals (Basel, Switzerland)
|
January 30, 2021
Mechanisms of Intranasal Deferoxamine in Neurodegenerative and Neurovascular Disease
Jacob Kosyakovsky, Jared M Fine, William H Frey, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 79) with videos related to
Sort By:
Page
of 8
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
November 28, 2007
Strategies for intranasal delivery of therapeutics for the prevention and treatment of neuroAIDS
Leah R Hanson, William H Frey
BMC Neuroscience
|
December 19, 2008
Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease
Leah R Hanson, William H Frey
Neuroscience Letters
|
March 6, 2012
Intranasal delivery of siRNA to the olfactory bulbs of mice via the olfactory nerve pathway
Dan B Renner, William H Frey, Leah R Hanson
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
January 4, 2020
Intranasal Insulin: a Treatment Strategy for Addiction
Bhavani Kashyap, Leah R Hanson, William H Frey Ii
The Journal of Pharmacology and Experimental Therapeutics
|
October 24, 2008
Novel vasoconstrictor formulation to enhance intranasal targeting of neuropeptide therapeutics to the central nervous system
Shyeilla V Dhuria, Leah R Hanson, William H Frey
Molecular Pharmaceutics
|
April 28, 2010
Trigeminal pathways deliver a low molecular weight drug from the nose to the brain and orofacial structures
Neil J Johnson, Leah R Hanson, William H Frey
Journal of Pharmaceutical Sciences
|
November 26, 2008
Intranasal drug targeting of hypocretin-1 (orexin-A) to the central nervous system
Shyeilla V Dhuria, Leah R Hanson, William H Frey
Journal of Pharmaceutical Sciences
|
October 31, 2009
Intranasal delivery to the central nervous system: mechanisms and experimental considerations
Shyeilla V Dhuria, Leah R Hanson, William H Frey
Pharmaceuticals (Basel, Switzerland)
|
February 26, 2025
Brain Glucose Hypometabolism and Brain Iron Accumulation as Therapeutic Targets for Alzheimer's Disease and Other CNS Disorders
Indira Y Rao, Leah R Hanson, William H Frey Ii
Pharmaceuticals (Basel, Switzerland)
|
January 30, 2021
Mechanisms of Intranasal Deferoxamine in Neurodegenerative and Neurovascular Disease
Jacob Kosyakovsky, Jared M Fine, William H Frey, et al.
Page
of 8